Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 77

Sort by

Sort Order Select

Journal Articles

Grndad and Disease Modifying Therapy (DMT): Shifts in Dmt Are Seen at the Adolescent/Young Adult Transition in Sickle Cell Disease in a Multi-Site Prospective Registry

Blood (2023) 142 (Supplement 1): 798.

https://doi.org/10.1182/blood-2023-174930

Published: 2023

Journal Articles

Habit Efficacy Trial: A Multi-Site Randomized Controlled Trial of Community Health Worker Support to Increase Hydroxyurea Adherence of Youth with Sickle Cell Disease

Nancy S. Green, Deepa Manwani, Banu Aygun, Abena Appiah-Kubi, Kim Smith-Whitley, Haomiao Jia, Arlene Smaldone

Blood (2023) 142 (Supplement 1): 3901.

https://doi.org/10.1182/blood-2023-190031

Published: 2023

Journal Articles

Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease: Final Interim Analysis Results from the Phase 2 Solace-Adults Study

Julie Kanter, Sarah Mennito, Santosh M Nair, Deepa Manwani, Abdullah Kutlar, Nirmish Shah, Deborah Keefe, Hariprasad Madhamshetty, Evgeniya Reshetnyak, Anisha E Mendonza, Darla K. Liles

Blood (2023) 142 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2023-173342

Published: 2023

Journal Articles

Cluster Analysis Reveals Distinct Subgroups with Severe Pain in Sickle Cell Disease: A Cross-Sectional Study Using the Grndad Multi-Center Registry

Martha O Kenney, Samuel Wilson, Morgan Rosser, Sophie Lanzkron, Julie Kanter, Amma T. Owusu-Ansah, Alice J. Cohen, Deepa Manwani, Jane A. Little

Blood (2023) 142 (Supplement 1): 930.

https://doi.org/10.1182/blood-2023-189214

Published: 2023

Journal Articles

COVID mRNA Vaccination Responses in Individuals with Sickle Cell Disease: An ASH Research Collaborative Clinical Trial Network Study

Alan Randall Anderson, John J Strouse, Deepa Manwani, Amanda M. Brandow, Elliott P. Vichinsky, Patrick Leavey, Joshua Field, Scott Hensley, Nicole Mortier, Sophie M. Lanzkron, Donna S. Neuberg, Charles S. Abrams

Blood (2023) 142 (Supplement 1): 2525.

https://doi.org/10.1182/blood-2023-187013

Published: 2023

Journal Articles

Steady-State Hemoglobin Is Associated with Self-Reported Ability to Perform Challenging Physical Function Activities, but Not Global Physical Function in Individuals with Sickle Cell Anemia

Elizabeth Linton, Jennifer Schrack, Julie Kanter, Deepa Manwani, Jane A. Little, Sophie Lanzkron

Blood (2023) 142 (Supplement 1): 3882.

https://doi.org/10.1182/blood-2023-188159

Published: 2023

Journal Articles

Risk Factors for Pediatric Acute Chest Syndrome Utilizing Machine Learning Techniques

Kerry A Morrone, Shweta Garg, Boudewijn Aasman, Erin Henninger, Mahendranath Rangareddy, Deepa Manwani, Selvin Soby, Parsa Mirhaji, Michael L Rinke

Blood (2023) 142 (Supplement 1): 5035.

https://doi.org/10.1182/blood-2023-174125

Published: 2023

Journal Articles

Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease

Richa Sharma, Ada Antypiuk, S. Zebulon Vance, Deepa Manwani, Quentinn Pearce, James E. Cox, Xiuli An, Karina Yazdanbakhsh, Francesca Vinchi

Blood (2023) 141 (25): 3091–3108.

https://doi.org/10.1182/blood.2022018026

Published: 2023

Includes: Supplemental data

Journal Articles

Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease

Huihui Li, Jacob S. Kazmi, Sungkyun Lee, Dachuan Zhang, Xin Gao, Maria Maryanovich, Lidiane Torres, Divij Verma, Libusha Kelly, Yelena Z. Ginzburg, Paul S. Frenette, Deepa Manwani

Blood (2023) 141 (2): 194–199.

https://doi.org/10.1182/blood.2022016218

Published: 2023

Includes: Multimedia, Supplemental data

Journal Articles

Assessing Multi-Level Barriers to Medication Adherence in Youth with Sickle Cell Disease Using Pharmacy-Based Prescription Refill Data

Arlene Smaldone, Deepa Manwani, Banu Aygun, Abena Appiah-Kubi, Kim Smith-Whitley, Nancy S. Green

Blood (2022) 140 (Supplement 1): 2149–2150.

https://doi.org/10.1182/blood-2022-157527

Published: 2022

Journal Articles

Similar Patient-Reported Quality of Life in the US and UK in Patients with Sickle Cell: A Comparative Grndad/Cousin Study

Sophie M. Lanzkron, Jane Alison Little, Daniel Semakula, Jessica Liang, Sara Stuart-Smith, Rachel Kesse-Adu, Julie Kanter, Alice J. Cohen, Sana Saif Ur Rehman, Stephanie H Guarino, Deepa Manwani, Payal C Desai, Kate Gardner

Blood (2022) 140 (Supplement 1): 8015–8016.

https://doi.org/10.1182/blood-2022-165504

Published: 2022

Journal Articles

Dietary Iron Restriction Alters Microbiota-Host Crosstalk and Protects Against Vaso-Occlusion and Organ Damage in Sickle Cell Disease Mice

Huihui Li, Jacob S Kazmi, Sungkyun Lee, Dachuan Zhang, Xin Gao, Maria Marianovich, Lidiane S. Torres, Divij Verma, Libusha Kelly, Yelena Ginzburg, Paul S. Frenette, Deepa Manwani

Blood (2022) 140 (Supplement 1): 439–440.

https://doi.org/10.1182/blood-2022-162772

Published: 2022

Journal Articles

Active Study: Impact of Voxelotor on Sleep Quality, Physical Activity, and Patient-Reported Outcomes

Nirmish Shah, Clark Brown, Biree Andemariam, Modupe Idowu, Alexander Glaros, Jeffrey Glassberg, Robert M Cronin, Barbara Moehring, Carolyn Hoppe, Sandy Dixon, Deepa Manwani

Blood (2022) 140 (Supplement 1): 5411–5413.

https://doi.org/10.1182/blood-2022-168317

Published: 2022

Journal Articles

Heme and Iron Aggravate Tissue Damage in Sickle Cell Disease By Driving Macrophage Functional Reprogramming through the Coordinated Suppression of Efferocytosis and Mitochondrial Metabolism

Richa Sharma, S. Zebulon Vance, Ada Antypiuk, Deepa Manwani, Quentinn Pearce, James E. Cox, Xiuli An, Karina Yazdanbakhsh, Francesca Vinchi

Blood (2022) 140 (Supplement 1): 2456–2457.

https://doi.org/10.1182/blood-2022-165364

Published: 2022

Journal Articles

Impact of MRA Echo Time on Stroke Prevention Therapy in Pediatric Patients with Sickle Cell Disease

William Beau Mitchell, Kaitlin L Strumph, Kerry A Morrone, Parmpreet Dhillon, Kevin Hsu, Deepa Manwani

Blood (2022) 140 (Supplement 1): 5437.

https://doi.org/10.1182/blood-2022-171058

Published: 2022

Journal Articles

Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease

Alice Tang, Ana Nicolle Strat, Mahmudur Rahman, Helen Zhang, Weili Bao, Yunfeng Liu, David Shi, Xiuli An, Deepa Manwani, Patricia Shi, Karina Yazdanbakhsh, Avital Mendelson

Blood (2021) 138 (24): 2570–2582.

https://doi.org/10.1182/blood.2021012663

Published: 2021

Includes: Supplemental data

Journal Articles

Pediatric Hydroxyurea Treatment Patterns, Sickle Cell Disease-Related Complication Rates, and Costs in a Large US Administrative Claims Database: A Retrospective Analysis

Deepa Manwani, Arthur Burnett, Jincy Paulose, Glorian P. Yen, Tanya Burton, Amy Anderson, Sara Wang, Soyon Lee, Santosh L. Saraf

Blood (2021) 138 (Supplement 1): 4055.

https://doi.org/10.1182/blood-2021-147956

Published: 2021

Journal Articles

Early Evaluation of the Use of Crizanlizumab in Sickle Cell Disease: A National Alliance of Sickle Cell Centers Study

Julie Kanter, Gerhard Hellemann, Alice J. Cohen, Deepa Manwani, Modupe Idowu, Stephanie Guarino, Sana Saif Ur Rehman, Marsha Treadwell, E. Leila Jerome Clay, Amma Owusu-Ansah, Jane A. Little, Payal Desai, Mohan Madisetti, Sophie M. Lanzkron

Blood (2021) 138 (Supplement 1): 3113.

https://doi.org/10.1182/blood-2021-153136

Published: 2021

Journal Articles

Rare Cases of Infusion-Related Reactions (IRRs) Presenting As Pain Events during or after Crizanlizumab Infusion in Patients (Pts) with Sickle Cell Disease (SCD): A Systematic Evaluation of Post-Marketing (PM) Reports

Julie Kanter, Amit Shah, Vikas Joshi, Harshit Mehta, Michael Levine, Uma Arunagiri, Jincy Paulose, Breanne Donohue, Alissa Scalera, Deepa Manwani

Blood (2021) 138 (Supplement 1): 3112.

https://doi.org/10.1182/blood-2021-152362

Published: 2021

Journal Articles

Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease

Yunfeng Liu, Mouli Pal, Weili Bao, Patricia A. Shi, Cheryl A. Lobo, Xiuli An, Deepa Manwani, Hui Zhong, Karina Yazdanbakhsh

Blood (2021) 138 (13): 1162–1171.

https://doi.org/10.1182/blood.2021011629

Published: 2021

Includes: Supplemental data

NARROW

Grndad and Disease Modifying Therapy (DMT): Shifts in Dmt Are Seen at the Adolescent/Young Adult Transition in Sickle Cell Disease in a Multi-Site Prospective Registry

Habit Efficacy Trial: A Multi-Site Randomized Controlled Trial of Community Health Worker Support to Increase Hydroxyurea Adherence of Youth with Sickle Cell Disease

Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease: Final Interim Analysis Results from the Phase 2 Solace-Adults Study

Cluster Analysis Reveals Distinct Subgroups with Severe Pain in Sickle Cell Disease: A Cross-Sectional Study Using the Grndad Multi-Center Registry

COVID mRNA Vaccination Responses in Individuals with Sickle Cell Disease: An ASH Research Collaborative Clinical Trial Network Study

Steady-State Hemoglobin Is Associated with Self-Reported Ability to Perform Challenging Physical Function Activities, but Not Global Physical Function in Individuals with Sickle Cell Anemia

Risk Factors for Pediatric Acute Chest Syndrome Utilizing Machine Learning Techniques

Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease

Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease

Assessing Multi-Level Barriers to Medication Adherence in Youth with Sickle Cell Disease Using Pharmacy-Based Prescription Refill Data

Similar Patient-Reported Quality of Life in the US and UK in Patients with Sickle Cell: A Comparative Grndad/Cousin Study

Dietary Iron Restriction Alters Microbiota-Host Crosstalk and Protects Against Vaso-Occlusion and Organ Damage in Sickle Cell Disease Mice

Active Study: Impact of Voxelotor on Sleep Quality, Physical Activity, and Patient-Reported Outcomes

Heme and Iron Aggravate Tissue Damage in Sickle Cell Disease By Driving Macrophage Functional Reprogramming through the Coordinated Suppression of Efferocytosis and Mitochondrial Metabolism

Impact of MRA Echo Time on Stroke Prevention Therapy in Pediatric Patients with Sickle Cell Disease

Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease

Pediatric Hydroxyurea Treatment Patterns, Sickle Cell Disease-Related Complication Rates, and Costs in a Large US Administrative Claims Database: A Retrospective Analysis

Early Evaluation of the Use of Crizanlizumab in Sickle Cell Disease: A National Alliance of Sickle Cell Centers Study

Rare Cases of Infusion-Related Reactions (IRRs) Presenting As Pain Events during or after Crizanlizumab Infusion in Patients (Pts) with Sickle Cell Disease (SCD): A Systematic Evaluation of Post-Marketing (PM) Reports

Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only